• Medicine
  • 29 de abril
  • FDA to approve AstraZeneca's Camizestrant
    2
  • FDA to approve AstraZeneca's Truqap (capivasertib)
    2
  • FDA to approve Axsome Therapeutics AXS-05
    2
  • 30 de dezembro
  • CDC to issue Level 3 warning by December 31
    2
  • FDA approves Retatrutide this year?
    2